256 related articles for article (PubMed ID: 33801810)
1. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography.
González-Gómez R; Pazo-Cid RA; Sarría L; Morcillo MÁ; Schuhmacher AJ
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33801810
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography.
Ruiz-López E; Calatayud-Pérez J; Castells-Yus I; Gimeno-Peribáñez MJ; Mendoza-Calvo N; Morcillo MÁ; Schuhmacher AJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008238
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
[TBL] [Abstract][Full Text] [Related]
5. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
[TBL] [Abstract][Full Text] [Related]
7. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
Rose DM; Delbeke D; Beauchamp RD; Chapman WC; Sandler MP; Sharp KW; Richards WO; Wright JK; Frexes ME; Pinson CW; Leach SD
Ann Surg; 1999 May; 229(5):729-37; discussion 737-8. PubMed ID: 10235532
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endoscopic ultrasound guided fine needle aspiration and PET/CT in preoperative diagnosis of pancreatic adenocarcinoma.
Lai JP; Yue Y; Zhang W; Zhou Y; Frishberg D; Jamil LH; Mirocha JM; Guindi M; Balzer B; Bose S; Cao D; Lo S; Fan X; Rutgers JK
Pancreatology; 2017; 17(4):617-622. PubMed ID: 28501471
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of
Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
11. A review study on early detection of pancreatic ductal adenocarcinoma using artificial intelligence assisted diagnostic methods.
Sijithra PC; Santhi N; Ramasamy N
Eur J Radiol; 2023 Sep; 166():110972. PubMed ID: 37454557
[TBL] [Abstract][Full Text] [Related]
12. Multiparameter diagnostic model based on
Wang G; Du L; Lu X; Chen S; Bi X; Zhang M; Luan X; Xu X; Zhang Z; Xu B; Yang J
Quant Imaging Med Surg; 2023 Sep; 13(9):5653-5663. PubMed ID: 37711769
[TBL] [Abstract][Full Text] [Related]
13. Radiomics model of dual-time 2-[
Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
[TBL] [Abstract][Full Text] [Related]
14. Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Kurland BF; Wiggins JR; Coche A; Fontan C; Bouvet Y; Webner P; Divgi C; Linden HM
Oncologist; 2020 Oct; 25(10):835-844. PubMed ID: 32374053
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
16. Imaging for pancreatic ductal adenocarcinoma.
Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
[TBL] [Abstract][Full Text] [Related]
17. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
18. Imaging modalities in the diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis of sensitivity, specificity and diagnostic accuracy.
Toft J; Hadden WJ; Laurence JM; Lam V; Yuen L; Janssen A; Pleass H
Eur J Radiol; 2017 Jul; 92():17-23. PubMed ID: 28624015
[TBL] [Abstract][Full Text] [Related]
19. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
[TBL] [Abstract][Full Text] [Related]
20. Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma.
Zhang Y; Huang ZX; Song B
World J Gastroenterol; 2021 Jun; 27(22):3037-3049. PubMed ID: 34168406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
